“Case Studies in Neuroscience” provides a forum for human or animal subjects studies that cannot be replicated experimentally (e.g., they report the neurological effects of a rare disease), but provide unique insights into mechanisms of neural function (either at the cellular or systems level). Clinical case studies that describe the treatment of a patient with a rare medical condition are NOT appropriate for this category, and will be rejected without peer review. Acceptable submissions must provide insights into mechanisms of neural function, and/or how those mechanisms are altered by a disease process. Authors are encouraged to consult with the Editor-in-Chief to determine if their manuscript qualifies for submission as “Case Studies in Neuroscience”.


The key elements of such articles are:
  • The title must begin "Case Studies in Neuroscience:..............." with the specific title following the colon.
  • Articles must be limited to studies with data – this is not a platform for presenting theories.
  • Text including references should be limited to 3000 words (approximately 3 printed journal pages). The number of figures and tables should be commensurate with the amount of data reported. We expect Case Studies articles to be no more than 5 printed journal pages.
  • There must be critical statistical consideration so that even when n=1, the major outcome(s) are qualitatively reliable, and, to the extent possible, quantitatively robust.
  • The Discussion must clearly present the limits on experimental design/methods based on the particular situation, should discuss general applicability of results, and justify why the case is of value.
  • The article must support a broader message than merely the description of findings, and be of instructional value to readers.


Case Studies in Neuroscience are not intended to report the following:
  • The medical treatment of a patient with a rare disease
  • Preliminary experimental findings that could feasibly be replicated in additional animal or human subjects